Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulantsA "SMART" design for building individualized treatment sequencesA randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic)Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challengesComparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials.Comparing Auditory Noise Treatment with Stimulant Medication on Cognitive Task Performance in Children with Attention Deficit Hyperactivity Disorder: Results from a Pilot Study.Differences in Speech Recognition Between Children with Attention Deficits and Typically Developed Children Disappear When Exposed to 65 dB of Auditory Noise.Catecholaminergic challenge uncovers distinct Pavlovian and instrumental mechanisms of motivated (in)actionA randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate.Methylphenidate use and school performance among primary school children: a descriptive study.An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.Working memory capacity predicts effects of methylphenidate on reversal learningPsychostimulant and sensory stimulation interventions that target the reading and math deficits of students with ADHD.An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder.Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials.Methylphenidate-Related Improvements in Math Performance Cannot Be Explained by Better Cognitive Functioning or Higher Academic Motivation: Evidence From a Randomized Controlled Trial.Coaching for College Students with ADHD.The novel use of objective laboratory school tasks to measure stress responses in children with ADHD.Methylphenidate during early consolidation affects long-term associative memory retrieval depending on baseline catecholamines.Methylphenidate in children with ADHD with or without learning disability.The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD.Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD.Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial.Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder.Studies on Paliperidone in OROS Tablets: Extraction Procedure and Chromatographic Analysis
P2860
Q22061981-ED240A6D-3407-43D8-93AF-C02B43FDFE3BQ22241445-CFCA8F15-3D56-40B2-8052-9FD3DFD97DDAQ24619631-86F9FABF-A8AD-49C9-8BB1-3AF2CDF62B03Q26779556-3B293F19-35F5-496A-8AE6-2C3FD205C6A8Q26822392-5E6D2428-099C-48AB-A786-0E609098F158Q27692676-0F51D441-39B8-452D-B50B-E190DD767E18Q30374187-6F01ED56-59D9-45FB-AF20-AE3C6ABEE7A4Q30391541-831FFCBE-4678-4E22-AB63-A5AB34C50936Q33688413-4017110D-E33B-4FB0-A6C9-92B056CA33AFQ34719188-77AD1A3D-C5EC-4DFB-91EF-4B2CD4C2BCD3Q35183156-C2266750-9C25-4CFF-98B3-6EAA8D70CCDFQ35871766-57FCDC15-D6DB-495A-92DF-2C239BD766D5Q36327312-34E76C97-B7A7-408E-B435-F5DDB8183DDDQ36695980-D1CBA025-C34D-4A02-8111-B830C38889A0Q37103313-51687A1E-0728-44A0-A71F-E56E418EC02DQ37979638-A4B783B4-A90D-42BE-8BFA-E18FD584FB85Q38067497-E87F07CE-31CC-4F62-A319-938F8887D2EEQ38101134-389BFF15-8951-422A-A22F-31538A5A943DQ38239633-6CA525DD-067F-47F3-8FF8-841F19BAD5F6Q38663390-9A94A9A0-B78F-4F12-871F-D55637C088E7Q38728143-BD436AD9-B515-4CD4-BACA-92EB2439BF2EQ38991314-DC9F0DEE-5B01-42F1-B0FE-4D3F6CE73167Q39531095-E176CED8-45A1-46D6-A581-04F8FD83AFBCQ42000414-B35C14CC-9DC9-404A-BF9E-9FCE98705350Q46024625-BFA9C377-EBAB-4C9B-A954-17730ACA662EQ47826858-D306F4E3-93A6-4032-B023-EAEEC8F8C659Q48103802-D2278102-A7C8-41EA-A663-22F049EFBE5FQ48883847-046AB6BF-5439-48B3-A4F8-9920226BE00FQ50659644-22586DBC-C11E-4DED-A83E-705073F56C29Q50675975-560B79A4-A535-4209-BCFF-2BCD964C7253Q58691303-A00AC3C0-1584-4509-B112-F55BEBC313F5
P2860
Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@ast
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@en
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@nl
type
label
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@ast
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@en
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@nl
prefLabel
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@ast
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@en
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@nl
P2093
P2860
P356
P1476
Academic, behavioral, and cogn ...... deficit/hyperactivity disorder
@en
P2093
David Williamson
H Lynn Starr
Matthew Brams
Robert B Armstrong
Sabrina Schuck
Sharon B Wigal
P2860
P304
P356
10.1089/CAP.2010.0047
P577
2011-04-13T00:00:00Z